[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate | 604-34-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate
• CAS: 604-34-2
• 化学式: C₄₇H₇₆O₂
• 分子量: 673.1
• InChiKey: IMXSFYNMSOULQS-WIMJHLADSA-N

物化性质

• 熔点：
  19 °C
• 沸点：
  697.9±54.0 °C(Predicted)
• 密度：
  0.97±0.1 g/cm3(Predicted)
• 溶解度：
  氯仿（微溶）、乙酸乙酯（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  15.6
• 重原子数：
  49
• 可旋转键数：
  21
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.77
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• WGK Germany：
  3

制备方法与用途

生物活性的cholesteryl arachidonate 是一种内源性代谢产物。

Human Endogenous Metabolite

文献信息

• SUBCUTANEOUSLY INFUSIBLE LEVODOPA PRODRUG COMPOSITIONS AND METHODS OF INFUSION
  申请人：Heller Ephraim

  公开号：US20140088192A1

  公开（公告）日：2014-03-27

  The invention features methods compositions and infusion pumps for infusing levodopa prodrugs (e.g., levodopa esters, levodopa amides, levodopa carboxamides, and levodopa sulfonamides) for the treatment of Parkinson's disease.

  这项发明涉及用于治疗帕金森病的注射泵、方法和组合物，用于注射左旋多巴前药（例如左旋多巴酯类、左旋多巴酰胺类、左旋多巴羧酰胺类和左旋多巴磺酰胺类）。
• External preparation
  申请人：Sansho Seiyaku Co., Ltd.

  公开号：EP0355842A2

  公开（公告）日：1990-02-28

  This invention provides an external preparation effectively preventing skin pigmentation caused by melanin production, i.e. spots or freckle, and having also superior actions on fair-skin making up, the external preparation containing unsaturated straight-­chain fatty acids or unsaturated straight-chain aliphatic alcohols or the derivatives thereof as effective ingredients.

  本发明提供了一种外用制剂，可有效防止因黑色素生成而引起的皮肤色素沉着，即色斑或雀斑，同时对白皙皮肤的妆容也有卓越功效，该外用制剂含有不饱和直链脂肪酸或不饱和直链脂肪醇或其衍生物作为有效成分。
• Implants for localized drug delivery and methods of use thereof
  申请人：The Regents of the University of California

  公开号：US10912933B2

  公开（公告）日：2021-02-09

  Provided herein is an implant for delivering a hydrophobic active agent to a target tissue. The implant may include a scaffold defining a first surface and a second surface opposite the first surface, wherein the scaffold is substantially impermeable to a hydrophobic active agent, and a silicone tubing having a wall permeable to the active agent, wherein a first length of the silicone tubing is affixed to the first surface of the scaffold, wherein the two ends of the silicone tubing extend from the first surface, and wherein a path outlined by a second length of the tubing within the first length is circuitous. Also provided is a method of using the implant to locally deliver a hydrophobic active agent to a target tissue, and kits that find use in performing the present method.

  本文提供了一种向目标组织输送疏水活性剂的植入物。该植入物可包括界定第一表面和与第一表面相对的第二表面的支架，其中支架基本上不渗透疏水活性剂，以及具有可渗透活性剂壁的硅胶管，其中硅胶管的第一长度贴在支架的第一表面上，其中硅胶管的两端从第一表面延伸，并且第一长度内的第二长度的硅胶管所勾勒的路径是迂回的。此外，还提供了一种使用植入物向目标组织局部递送疏水活性剂的方法，以及可用于实施本方法的试剂盒。
• IMPLANTS FOR LOCALIZED DRUG DELIVERY AND METHODS OF USE THEREOF
  申请人：The Regents of the University of California

  公开号：EP3183026A1

  公开（公告）日：2017-06-28
• Implants for Localized Drug Delivery and Methods of Use Thereof
  申请人：KIRIAKIS Jim

  公开号：US20170224970A1

  公开（公告）日：2017-08-10

  Provided herein is an implant for delivering a hydrophobic active agent to a target tissue. The implant may include a scaffold defining a first surface and a second surface opposite the first surface, wherein the scaffold is substantially impermeable to a hydrophobic active agent, and a silicone tubing having a wall permeable to the active agent, wherein a first length of the silicone tubing is affixed to the first surface of the scaffold, wherein the two ends of the silicone tubing extend from the first surface and wherein a path outlined by a second length of the tubing within the first length is circuitous. Also provided is a method of using the implant to locally deliver a hydrophobic active agent to a target tissue, and kits that find use in performing the present method.